[go: up one dir, main page]

BR9202771A - Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera - Google Patents

Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera

Info

Publication number
BR9202771A
BR9202771A BR929202771A BR9202771A BR9202771A BR 9202771 A BR9202771 A BR 9202771A BR 929202771 A BR929202771 A BR 929202771A BR 9202771 A BR9202771 A BR 9202771A BR 9202771 A BR9202771 A BR 9202771A
Authority
BR
Brazil
Prior art keywords
blood
microsphere
compounds
introduce
compound
Prior art date
Application number
BR929202771A
Other languages
English (en)
Inventor
Susan Mancini Cady
William David Steber
Philip Wayne Hayes
Mary Ehlers Doscher
Kurt Allen Schwinghammer
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of BR9202771A publication Critical patent/BR9202771A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR929202771A 1991-07-23 1992-07-20 Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera BR9202771A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73443091A 1991-07-23 1991-07-23

Publications (1)

Publication Number Publication Date
BR9202771A true BR9202771A (pt) 1993-03-23

Family

ID=24951666

Family Applications (1)

Application Number Title Priority Date Filing Date
BR929202771A BR9202771A (pt) 1991-07-23 1992-07-20 Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera

Country Status (21)

Country Link
US (1) US6340671B1 (pt)
EP (1) EP0525307B1 (pt)
JP (1) JP3470904B2 (pt)
KR (1) KR100235550B1 (pt)
CN (1) CN1046852C (pt)
AT (1) ATE134873T1 (pt)
AU (1) AU651229B2 (pt)
BR (1) BR9202771A (pt)
CA (1) CA2074348C (pt)
DE (1) DE69208765T2 (pt)
DK (1) DK0525307T3 (pt)
ES (1) ES2086022T3 (pt)
GR (1) GR3019234T3 (pt)
HK (1) HK1000005A1 (pt)
HU (1) HU220595B1 (pt)
IE (1) IE74401B1 (pt)
IL (1) IL102567A (pt)
MX (1) MX9204135A (pt)
NZ (1) NZ243619A (pt)
TW (1) TW201696B (pt)
ZA (1) ZA925522B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5686092A (en) * 1992-11-24 1997-11-11 Alkermes Controlled Therapeutics Inc. Ii Growth promoters for animals
DE4308282C2 (de) * 1993-03-16 1994-12-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US8663692B1 (en) * 1999-05-07 2014-03-04 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
MXPA01011343A (es) * 1999-05-07 2002-06-04 Pharmasol Gmbh Particulas de lipidos a base de mezclas de lipidos liquidos y solidos asi como procedimiento para su produccion.
DE60133706T2 (de) * 2000-10-10 2009-07-02 Wyeth Holdings Corp. Stabilisierte Arzneizusammensetzungen zur parenteralen Vearbreichung
FR2852843B1 (fr) 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
NZ534939A (en) * 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
EP2485725A2 (en) 2009-10-07 2012-08-15 Wyeth LLC Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
ITUB20153652A1 (it) 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici
WO2018189314A1 (en) 2017-04-13 2018-10-18 Ceva Sante Animale Composition for treating worms infestations
MX2021010043A (es) * 2019-02-21 2022-07-19 Chromadex Inc Uso de nicotinamida ribósido, ácido nicotinico ribósido, compuestos de nicotinil ribósido reducido y derivados de compuestos de nicotinil ribósido en formulaciones.
JP7558197B2 (ja) 2019-05-03 2024-09-30 インターベット インターナショナル ベー. フェー. 注射可能な医薬組成物及びその使用
US20230310386A1 (en) 2020-05-20 2023-10-05 Intervet Inc. Injectable pharmaceutical compositions and uses thereof
WO2022263505A1 (en) * 2021-06-16 2022-12-22 Société des Produits Nestlé S.A. Methods of solid phase wax coating of an active ingredient
CN119677500A (zh) 2022-06-30 2025-03-21 维克公司 德舍瑞林在与pk/pd相互作用相关的非人类哺乳动物化学去势中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3659022A (en) * 1967-11-13 1972-04-25 Upjohn Co Methods of preventing impregnation
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US5169956A (en) * 1984-06-05 1992-12-08 American Cyanamid Company Macrolide antibiotic compounds
US5106994A (en) * 1984-06-05 1992-04-21 American Cyanamid Company Agents and method of production thereof
ES2039219T3 (es) * 1986-08-11 1993-09-16 American Cyanamid Company Composiciones para administracion parenteral y su uso.
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
ATE103173T1 (de) * 1989-02-28 1994-04-15 American Cyanamid Co Bolus mit lang andauernder wirkstoffabgabe, wirksam bei der prophylaxe, behandlung oder bekaempfung des befalls bei wiederkaeuern durch fadenwuermer, milben und endo- und ektoparasiten.
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
US5346698A (en) * 1991-01-15 1994-09-13 Mycogen Corporation Synergistic pesticidal compositions
US5192546A (en) * 1991-01-15 1993-03-09 Mycogen Corporation Synergistic pesticidal compositions
US5185108A (en) * 1991-07-10 1993-02-09 The B. F. Goodrich Company Method for producing wax microspheres
JP4654917B2 (ja) 2006-01-12 2011-03-23 日産自動車株式会社 車体後部構造

Also Published As

Publication number Publication date
IE922373A1 (en) 1993-01-27
US6340671B1 (en) 2002-01-22
IL102567A (en) 1996-10-31
CN1046852C (zh) 1999-12-01
KR930001904A (ko) 1993-02-22
DE69208765T2 (de) 1996-09-26
ATE134873T1 (de) 1996-03-15
EP0525307A1 (en) 1993-02-03
CN1068735A (zh) 1993-02-10
CA2074348C (en) 2004-02-17
MX9204135A (es) 1993-01-01
IE74401B1 (en) 1997-07-30
NZ243619A (en) 1994-12-22
HK1000005A1 (en) 1997-10-03
DE69208765D1 (de) 1996-04-11
ZA925522B (en) 1993-04-28
HU9202404D0 (en) 1992-10-28
JP3470904B2 (ja) 2003-11-25
TW201696B (pt) 1993-03-11
HUT62454A (en) 1993-05-28
KR100235550B1 (ko) 1999-12-15
EP0525307B1 (en) 1996-03-06
CA2074348A1 (en) 1993-01-24
GR3019234T3 (en) 1996-06-30
AU651229B2 (en) 1994-07-14
DK0525307T3 (da) 1996-04-01
HU220595B1 (hu) 2002-03-28
IL102567A0 (en) 1993-01-14
ES2086022T3 (es) 1996-06-16
AU2047292A (en) 1993-01-28
JPH05194211A (ja) 1993-08-03

Similar Documents

Publication Publication Date Title
BR9202771A (pt) Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera
PT2013119442B (pt) Composições veterinárias orais parasiticidas compreendendo agentes activos de actuação sistémica, métodos e as suas utilizações
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
BRPI0416752A (pt) composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica
AU781682B2 (en) Sustained-release compositions for parenteral administration
CY1108145T1 (el) Σταθερες συνθεσεις για παρεντερικη χορηγηση
BRPI0406875A (pt) Derivados de monossacarìdeo de avermectina tendo propriedades pesticidas
ATE207492T1 (de) Difluoroavermectin-derivate
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
BRPI0407271A (pt) Composição anti-helmìntica
AU2006203347C1 (en) Stabilised formulation
ES2132283T3 (es) Derivados n-heteroaril sustituidos de propanamida utiles en el tratamiento de enfermedades cardiovasculares.
DE3573707D1 (de) Anticoccidial compostions
KR950703956A (ko) 순환 장애 개선제[circulatory disturbance ameliorant]
FR2534809B1 (fr) Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci
PT1100463E (pt) Novas formulacoes injectaveis contendo ramoplanina
ES2102370T3 (es) Composicion antiparasitaria para uso animal.
BR0016427A (pt) Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica
JPS5480426A (en) Agent for prophylaxis and remedy of mycoplasmosis

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal